These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 4268267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of severe arterial hypertension with a new peripheral vasodilator agent (minoxidil)].
    Angelino PF, Lavezzaro G.
    Minerva Cardioangiol; 1979 Jun; 27(6):359-64. PubMed ID: 381979
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Minoxidil in refractory hypertension: benefits, risks.
    Marquez-Julio A, From GL, Uldall PR.
    Proc Eur Dial Transplant Assoc; 1977 Jun; 14():501-8. PubMed ID: 600967
    [Abstract] [Full Text] [Related]

  • 5. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
    Gilmore E, Weil J, Chidsey C.
    N Engl J Med; 1970 Mar 05; 282(10):521-7. PubMed ID: 4391708
    [No Abstract] [Full Text] [Related]

  • 6. Control of hypertension and reversal of renal failure in scleroderma.
    Mitnick PD, Feig PU.
    N Engl J Med; 1978 Oct 19; 299(16):871-2. PubMed ID: 692580
    [No Abstract] [Full Text] [Related]

  • 7. Long-term minoxidil therapy in patients with refractory hypertension and renal disease.
    Bennett WM, Hartnett M, Kuehnel E, McDonald WJ, Porter GA.
    Proc Clin Dial Transplant Forum; 1978 Oct 19; 6():80-4. PubMed ID: 1029893
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Minoxidil in treatment resistant hypertension].
    Tenschert W, Vetter W, Studer A, Reuteler H, Furrer J, Nussberger J, Siegenthaler W.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1869-73. PubMed ID: 531565
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of malignant hypertension.
    Grim CE.
    Compr Ther; 1980 May 08; 6(5):43-8. PubMed ID: 7379487
    [No Abstract] [Full Text] [Related]

  • 20. Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
    Markenson JA, Sherman RL.
    Arthritis Rheum; 1979 Oct 08; 22(10):1132-4. PubMed ID: 158363
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.